UCSF Benioff Children's Hospital Antimicrobial Susceptibility: Enterococcal Isolates Susceptibilities

The number of isolates and susceptibilities are based on combined data from 2016-2018. Numers represent % of isolates susceptible. Isolate numbers and 95% confidence intervals are provided to gauge precision of susceptibility estimates.

Inpatient Pediatric Enterococcal Isolates (All Sites of Isolation)

 

Total Isolates

Ampicillin

Daptomycin

Linezolid

Vancomycin

All Enterococcus isolates

125

88

(81,93)

46 (100)#

(37,56)

100

(97,100)

94

(88,97)

Enterococcus faecalis

55

100

(94,100)

51 (100)#

37,65)

100

(94,100)

100

(94,100)

Enterococcus faecium

8*

42

(9,76)

11 (100)#

(0,53)

100

(63,100)

74

(35,97)

Enterococcus gallinarum

2*

100

(16,100)

0 (100)#

(0,84)

100

(16,100)

N/A

Enterococcus spp (unspecified)

45

92

(80,98)

57 (100)#

(42,71)

100

(93,100)

98

(89,100)

*When fewer than 30 isolates are reported, the susceptibility estimate may not be a robust estimate of population susceptibility.

# Number in parentheses represents the percentage of isolates both fully susceptible and susceptible-dose dependent to daptomycin. Susceptible-dose dependent isolates are those with MIC 2 to 4 micrograms/mL for which a high dose of daptomycin is anticipated to be active. Consult Pediatric ASP or ID for guidance on treating isolates reported as susceptible-dose dependent.